Functional Variants of the 5-Methyltetrahydrofolate-homocysteine Methyltransferase Gene Significantly Increase Susceptibility to Prostate Cancer: Results from an Ethnic Han Chinese Population

Yuan-Yuan Qu,Shu-Xian Zhou,Xuan Zhang,Rui Zhao,Cheng-Yuan Gu,Kun Chang,Xiao-Qun Yang,Hua-Lei Gan,Bo Dai,Hai-Liang Zhang,Guo-Hai Shi,Yao Zhu,Ding-Wei Ye,Jian-Yuan Zhao
DOI: https://doi.org/10.1038/srep36264
IF: 4.6
2016-01-01
Scientific Reports
Abstract:Aberrant DNA methylation has been implicated in prostate carcinogenesis. The one-carbon metabolism pathway and related metabolites determine cellular DNA methylation and thus is thought to play a pivotal role in PCa occurrence. This study aimed to investigate the contribution of genetic variants in one-carbon metabolism genes to prostate cancer (PCa) risk and the underlying biological mechanisms. In this hospital-based case-control study of 1817 PCa cases and 2026 cancer-free controls, we genotyped six polymorphisms in three one-carbon metabolism genes and assessed their association with the risk of PCa. We found two noncoding MTR variants, rs28372871 T > G and rs1131450 G > A, were independently associated with a significantly increased risk of PCa. The rs28372871 GG genotype (adjusted OR = 1.40, P = 0.004) and rs1131450 AA genotype (adjusted OR = 1.64, P = 0.007) exhibited 1.40-fold and 1.64-fold higher risk of PCa, respectively, compared with their respective homozygous wild-type genotypes. Further functional analyses revealed these two variants contribute to reducing MTR expression, elevating homocysteine and SAH levels, reducing methionine and SAM levels, increasing SAH/SAM ratio, and promoting the invasion of PCa cells in vitro . Collectively, our data suggest regulatory variants of the MTR gene significantly increase the PCa risk via decreasing methylation potential. These findings provide a novel molecular mechanism for the prostate carcinogenesis.
What problem does this paper attempt to address?